Pharmaceutical Treatment for Alzheimer’s Disease and Related Dementias: Utilization and Disparities

BACKGROUND: Four prescription drugs (donepezil, galantamine, memantine, and rivastigmine) are approved by the US FDA to treat symptoms of Alzheimer’s disease (AD). Even modest effectiveness could potentially reduce the population-level burden of AD and related dementias (ADRD), especially for women...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Alzheimers Dis
Autori principali: Barthold, Douglas, Joyce, Geoffrey, Ferido, Patricia, Drabo, Emmanuel F., Marcum, Zachary A., Gray, Shelly L., Zissimopoulos, Julie
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7825250/
https://ncbi.nlm.nih.gov/pubmed/32538845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-200133
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi